Clinical trial · Interventional
Mind Body Program for Fear of Recurrence
NCT03695406CI-TRIAL-00056265completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mind-Body Program for Fear of Recurrence | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Mind-Body Group Intervention
- interventionNames
- Behavioral: Mind-Body Program for Fear of Recurrence
Primary outcomes (2)
- measure
- Feasibility (i.e., retention at initial follow-up assessment)
- timeFrame
- Through study completion (approximately 5 months)
- description
- The primary metric for assessing Feasibility will be retention at the initial follow-up assessment. Reasons for ineligibility, refusal, or dropping out will be measured.
- measure
- Acceptability
- timeFrame
- During intervention group sessions (approximately 2 months)
- description
- The primary metric for assessing Acceptability will be a five-item, investigator developed self-report questionnaire. Following each study session, participants will be asked to rate (1=not at all to 5=very much) the enjoyableness, convenience, helpfulness, relevancy, odds of future use, and overall satisfaction of the session.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients must have a history of breast, lung, colorectal, hematologic, prostate, melanoma, or gynecological cancer (by medical record and/or self-report) 2. Completion of primary cancer treatment (radiation, surgery, and/or chemotherapy) between 3 to 30 months ago 3. Ages 18 and older (by medical record and/or self-report) Exclusion Criteria: 1. Self-reported inability to speak and write in English 2. Concurrent participation in weekly, group-based psychosocial or mind-body programs 3. Serious mental illness (by medical record and/or self-report) as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year. 4. Inability to travel to necessary study visits 5. No e-mail address to access online assessments
References
Publications (1)
- DERIVEDHall DL, Park ER, Cheung T, Davis RB, Yeh GY. A Pilot Mind-Body Resiliency Intervention Targeting Fear of Recurrence among Cancer Survivors. J Psychosom Res. 2020 Oct;137:110215. doi: 10.1016/j.jpsychores.2020.110215. Epub 2020 Aug 10. PMID 32818720